NEOG NEOGEN
Health Care · Russell 2000
Next earnings: Thu 7 Jan 2027 · estimated
What 6 analyst firms say about NEOGEN: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
5 rated views · 6 analyst/firm records · 6 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
- Russell 2000 · Safest consensus · 6MNot scored · Fewer than 5 analysts in the last 6 months (4)
Recent analyst activity · last 90 days
Our tracked history has 2 reports on NEOG from 2 analyst firms in the last 90 days (6 firms in the past year).
Comparing each firm's latest target with its previous one: 2 raised their price target.
Ratings, latest available report against the previous one: 1 upgrade and 0 downgrades.
Latest observed target change: Guggenheim raised its target from $12.00 (set 9 Jan 2026) to $14.00 on 30 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cjs Securities | Robert Labick | Buy | 10 Dec 2025 | 10.00 USD |
| Guggenheim | Subbu Nambi | Buy | 30 Sep 2026 | 14.00 USD |
| Piper Sandler | David Westenberg | Buy | 26 Aug 2026 | 14.00 USD |
| Weiss Ratings | Unnamed analyst | — | 7 Aug 2026 | — |
| William Blair | Brandon Vazquez | Hold | 21 Jul 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 23 Jan 2026 | 15.00 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 02:46 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.